Urology Times Innovation Celebration: Expert Insights

Interview articles featuring in-depth analysis of each innovation from urology experts.

Prostate-specific antigen–based screening ushers in an era of change

January 6th 2022

William J. Catalona, MD, explains how prostate-specific antigen (PSA) testing revolutionized screening and treatment of prostate cancer.

Dr. Khera and Dr. Pearlman discuss innovations in testosterone therapy

January 12th 2022

In this installment of our 50th Anniversary Innovation Celebration, Amy Pearlman, MD, interviews Mohit Khera, MD, MBA, MPH, on how advancements in testosterone therapy have changed treatment modalities across urology, providing patients with more efficacious, individualized care.

SUI treatment reaches "new frontier” with regenerative medicine and stem cell–based therapies

January 19th 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Melissa R. Kaufman, MD, PhD, FACS, discusses the innovative use of stem cell–derived treatments in urologic conditions such as stress urinary incontinence.

Dr. Atala discusses innovations in regenerative medicine

January 26th 2022

In this interview, Anthony Atala, MD, discusses how regenerative medicine and tissue engineering have greatly improved the quality of life for patients who have undergone urologic surgery.

Midurethral sling opens up treatment of stress urinary incontinence to more patients

February 2nd 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Howard Goldman, MD, discusses the development of the midurethral sling as a treatment for stress urinary incontinence.

Genetic testing and the precision medicine era of prostate cancer

February 9th 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Veda N. Giri, MD, highlights the role genetic testing has played in a new era of prostate cancer therapeutics.

How onabotulinumtoxinA “revolutionized” treatment of urologic conditions

February 16th 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Melissa R. Kaufman, MD, PhD, FACS, discusses the significance of onabotulinumtoxinA treatment in patients with overactive bladder.

Intermittent catheterization: From medical procedure to patient-controlled process

February 23rd 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, John Stoffel, MD, discusses the development of clean intermittent catheterization and how it has improved the care of patients with urologic conditions.

Dr. Burnett on Viagra: “This transformed the field in a significant way”

March 2nd 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Arthur L. Burnett, MD, MBA, FACS, discusses how sildenafil citrate (Viagra) has been an integral part of erectile dysfunction management for decades.

How active surveillance has changed the management of prostate cancer

March 9th 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Kara L. Watts, MD, discusses the emergence and increasing uptake of active surveillance as a management strategy for men with prostate cancer.